One engine for the entire pharma value chain — Drug discovery to bedside. Governed Healthcare AI, evidence-gated. Built for biopharma that can't afford to guess
In drug development, AI must be decision-grade and not just a suggestion engine.
#Hakase brings provenance, confidence, evidence-backed validation, human-in-the-loop review, safety constraints, and a tamper-evident audit trail thus making the output trustworthy enough to act on.
AI in #drugdevelopment should do more than predict and should shift from AI models → evidence systems and tell us:
-What supports the prediction.
-Where uncertainty remains.
-What evidence contradicts it.
-And whether the result is strong enough to influence the next experiment.
#DrugDevelopment doesn’t have a data problem. It has a continuity and reasoning problem. Evidence is generated across discovery, #preclinical, #clinical and #regulatory stages but context gets lost. Hakase aims to connect that evidence and reasoning across the lifecycle.